Your browser doesn't support javascript.
loading
Using Treg, Tr1, and Breg Expression Levels to Predict Clinical Responses to csDMARD Treatment in Drug-naive Patients With Rheumatoid Arthritis.
Hsieh, Ting-Yu; Lui, Shan-Wen; Lu, Jeng-Wei; Chen, Yen-Chen; Lin, Ting-Chun; Jheng, Wun-Long; Ho, Yi-Jung; Liu, Feng-Cheng.
Affiliation
  • Hsieh TY; School of Medicine, National Defense Medical Center, Taipei, Taiwan, R.O.C.
  • Lui SW; School of Medicine, National Defense Medical Center, Taipei, Taiwan, R.O.C.
  • Lu JW; Biotech Research and Innovation Centre, Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen, Denmark.
  • Chen YC; The Finsen Laboratory, Rigshospitalet/National University Hospital, Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen, Denmark.
  • Lin TC; Institute of Preventive Medicine, National Defense Medical Center, Taipei, Taiwan, R.O.C.
  • Jheng WL; Graduate Institute of Life Sciences, National Defense Medical Center, Taipei, Taiwan, R.O.C.
  • Ho YJ; Department of Translational Science, Massachusetts Laboratory for Engineering Medicine and Critical Data, Gloucester, MA, U.S.A.
  • Liu FC; Graduate Institute of Life Sciences, National Defense Medical Center, Taipei, Taiwan, R.O.C.; ejung330@gmail.com.
In Vivo ; 37(5): 2018-2027, 2023.
Article in En | MEDLINE | ID: mdl-37652509

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Arthritis, Rheumatoid / Autoimmune Diseases / Antirheumatic Agents / B-Lymphocytes, Regulatory Type of study: Prognostic_studies / Risk_factors_studies Limits: Humans Language: En Journal: In Vivo Journal subject: NEOPLASIAS Year: 2023 Document type: Article

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Arthritis, Rheumatoid / Autoimmune Diseases / Antirheumatic Agents / B-Lymphocytes, Regulatory Type of study: Prognostic_studies / Risk_factors_studies Limits: Humans Language: En Journal: In Vivo Journal subject: NEOPLASIAS Year: 2023 Document type: Article